Literature DB >> 1754886

Clinical assessment of venous thromboembolic risk in surgical patients.

J A Caprini1, J I Arcelus, J H Hasty, A C Tamhane, F Fabrega.   

Abstract

Prophylaxis against postoperative venous thromboembolism should be tailored according to the patient's level of risk. However, risk assessment is not yet in widespread use in surgical practice. In this study, 538 general surgical patients were prospectively assessed based on a scoring system containing 20 risk factors. Depending on the total risk factor score, the patients were grouped into low (0 to 1, 34.5%), moderate (2 to 4, 48.5%), or high risk (more than 4, 17.2%) categories. Statistically significant (p less than 0.0001) correlation was found between our results and those of three existing risk assessment systems. Overall, of the 538 patients, 37.2% received prophylaxis; 10%, 42.1%, and 76% received prophylaxis in the low-, moderate-, and high-risk categories, respectively. Mechanical prophylactic modalities (graduated elastic compression and sequential intermittent compression) were preferred over pharmacologic modalities. These results suggest that implementation of prophylaxis remains underutilized despite published reports, including NIH guidelines. Our results indicate that the majority of surgical patients seen in this suburban hospital have two or more risk factors for developing venous thromboembolism.

Entities:  

Mesh:

Year:  1991        PMID: 1754886

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  57 in total

Review 1.  A guide to venous thromboembolism risk factor assessment.

Authors:  G D Motykie; L P Zebala; J A Caprini; C E Lee; J I Arcelus; J J Reyna; E B Cohen
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.

Authors:  Christine Baumgartner; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  J Gen Intern Med       Date:  2019-06-24       Impact factor: 5.128

3.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy.

Authors:  Christoph Schregel; Hubert John; Marco Randazzo; Isabelle Keller
Journal:  World J Urol       Date:  2017-07-12       Impact factor: 4.226

Review 5.  Enhanced recovery after surgery: implementing a new standard of surgical care.

Authors:  Alon D Altman; Limor Helpman; Jacob McGee; Vanessa Samouëlian; Marie-Hélène Auclair; Harinder Brar; Gregg S Nelson
Journal:  CMAJ       Date:  2019-04-29       Impact factor: 8.262

6.  The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.

Authors:  Janet N Chu; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  Thromb Res       Date:  2017-04-12       Impact factor: 3.944

Review 7.  Anaesthetic perioperative management of patients with pancreatic cancer.

Authors:  Lesley De Pietri; Roberto Montalti; Bruno Begliomini
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 8.  Venous thromboembolism prophylaxis.

Authors:  Jonathan Laryea; Bradley Champagne
Journal:  Clin Colon Rectal Surg       Date:  2013-09

9.  Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomy.

Authors:  J A Caprini; J I Arcelus; M Laubach; G Size; K N Hoffman; R W Coats; S Blattner
Journal:  Surg Endosc       Date:  1995-03       Impact factor: 4.584

Review 10.  Impact on patient care: patient case through the continuum of care.

Authors:  Scott Kaatz
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.